Trial intelligence / Profile preview

Tranexamic Acid in Total Joint Arthroplasty

NCT03825939Phase 4Terminated

Sponsor
NYU Langone Health
Start
Apr 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tranexamic acid in hemorrhage, sponsored by NYU Langone Health. Started Apr 2015; status: terminated.

02

Drugs

tranexamic acid
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT03825939.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03825939.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call